This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Nov 4;29(11):e1626.

doi: 10.1093/oncolo/oyae199.

Correction to: Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors

No authors listed

PMID: 39215827
PMCID: PMC11546710
DOI: 10.1093/oncolo/oyae199

Published Erratum

Correction to: Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors

No authors listed. Oncologist. 2024.

. 2024 Nov 4;29(11):e1626.

doi: 10.1093/oncolo/oyae199.

PMID: 39215827
PMCID: PMC11546710
DOI: 10.1093/oncolo/oyae199

No abstract available

PubMed Disclaimer

Erratum for

Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors.
Jamison JK, Zhou M, Gelmann EP, Luk L, Bates SE, Califano A, Fojo T. Jamison JK, et al. Oncologist. 2024 Sep 6;29(9):817-e1213. doi: 10.1093/oncolo/oyae118. Oncologist. 2024. PMID: 38886159 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- PubMed Central
- Silverchair Information Systems